BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26724931)

  • 1. Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.
    Jin X; Schwabe K; Krauss JK; Alam M
    Exp Brain Res; 2016 Apr; 234(4):1105-18. PubMed ID: 26724931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats.
    Aristieta A; Ruiz-Ortega JA; Morera-Herreras T; Miguelez C; Ugedo L
    Exp Neurol; 2019 Dec; 322():113036. PubMed ID: 31425688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson's disease.
    Alam M; Capelle HH; Schwabe K; Krauss JK
    Brain Stimul; 2014; 7(1):13-20. PubMed ID: 24126192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered somatosensory cortex neuronal activity in a rat model of Parkinson's disease and levodopa-induced dyskinesias.
    Alam M; Rumpel R; Jin X; von Wrangel C; Tschirner SK; Krauss JK; Grothe C; Ratzka A; Schwabe K
    Exp Neurol; 2017 Aug; 294():19-31. PubMed ID: 28445715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats.
    Aristieta A; Ruiz-Ortega JA; Miguelez C; Morera-Herreras T; Ugedo L
    Neurobiol Dis; 2016 May; 89():88-100. PubMed ID: 26852950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
    Périer C; Marin C; Jimenez A; Bonastre M; Tolosa E; Hirsch EC
    J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
    Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M
    Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease.
    Marin C; Bonastre M; Fuentes M; Mullol J
    Pharmacol Biochem Behav; 2020 Oct; 197():173013. PubMed ID: 32758524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
    Jin X; Schwabe K; Krauss JK; Alam M
    Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of torsinA expression in the globus pallidus internus is associated with levodopa-induced dyskinesia in hemiparkinsonian rats.
    Yamada K; Goto S; Kaji R; Kuratsu J
    Neurosci Lett; 2006 Mar; 396(1):62-6. PubMed ID: 16325337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata.
    Gago B; Marin C; Rodríguez-Oroz MC; Obeso JA
    Synapse; 2013 Jul; 67(7):407-14. PubMed ID: 23404474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spike and Local Field Synchronization Between the Pedunculopontine Nucleus and Primary Motor Cortex in a Rat Model of Parkinson's Disease.
    Geng X; Wang X; He F; Zhang X; Xie J; Gao G; Han H; Yao X; Zhang H; Gao Y; Wang Y; Wang M
    Neuroscience; 2019 Apr; 404():470-483. PubMed ID: 30710670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal Entropy-Rate Feature of Entopeduncular Nucleus in Rat Model of Parkinson's Disease.
    Darbin O; Jin X; Von Wrangel C; Schwabe K; Nambu A; Naritoku DK; Krauss JK; Alam M
    Int J Neural Syst; 2016 Mar; 26(2):1550038. PubMed ID: 26711712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine.
    Ye T; Bartlett MJ; Sherman SJ; Falk T; Cowen SL
    Exp Neurol; 2021 Jun; 340():113670. PubMed ID: 33662379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term increase in coherence between the basal ganglia and motor cortex after asphyxial cardiac arrest and resuscitation in developing rats.
    Aravamuthan BR; Shoykhet M
    Pediatr Res; 2015 Oct; 78(4):371-9. PubMed ID: 26083760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal firing activity in the basal ganglia after striatal transplantation of dopamine neurons in hemiparkinsonian rats.
    Rumpel R; Alam M; Schwarz LM; Ratzka A; Jin X; Krauss JK; Grothe C; Schwabe K
    Neuroscience; 2017 Sep; 360():197-209. PubMed ID: 28790019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Dupre KB; Cruz AV; McCoy AJ; Delaville C; Gerber CM; Eyring KW; Walters JR
    Neurobiol Dis; 2016 Feb; 86():1-15. PubMed ID: 26586558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic labelling of metabotropic glutamate type 2/3 receptors in the hemi-parkinsonian rat brain.
    Kim E; Frouni I; Shaqfah J; Bédard D; Huot P
    J Chem Neuroanat; 2024 Jul; 138():102422. PubMed ID: 38657828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E; Lisci C; Stancampiano R; Fidalgo C; Collu M; Devoto P; Carta M
    Neurobiol Dis; 2013 Dec; 60():108-14. PubMed ID: 24004632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Shin KS; Zhao TT; Park KH; Park HJ; Hwang BY; Lee CK; Lee MK
    BMC Neurosci; 2015 Apr; 16():23. PubMed ID: 25896846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.